Wanxing Chai‐Ho

1.1k citations
24 papers · 298 indexed · 2 hit papers · h-index 6
Topics
CAR-T cell therapy research (8 papers)Virus-based gene therapy research (5 papers)Immunotherapy and Immune Responses (5 papers)
Journals
Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Wanxing Chai‐Ho

23 papers receiving 297 citations

Hit Papers

Pembrolizumab plus cetuximab in patients with recurrent o...20212026202220242021202550100150

Peers

Wanxing Chai‐Ho
Comparison fields: 5 of 42
  • Oncology 201
  • Immunology 85
  • Pulmonary and Respiratory Medicine 76
  • Otorhinolaryngology 75
  • Molecular Biology 66
Replace Raetasha Dabney with:
Raetasha Dabney United States
Simone K. Bendtsen Denmark
Javier Valdivia Spain
Cornedine J. de Gooijer Netherlands
Lorna Grove United Kingdom
Thiago Bueno de Oliveira Brazil
Jonathan Moreira United States
Yonglin Cai China
Stephen Jay Frank Israel
Eduardo Breda Portugal
Wanxing Chai‐Ho relative to Raetasha Dabney United States Raetasha Dabney's profile →
Citations per field
00.5×3.9×
Raetasha Dabney · 1×
Citations per year

Countries citing papers authored by Wanxing Chai‐Ho

Since Specialization
Citations

This map shows the geographic impact of Wanxing Chai‐Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanxing Chai‐Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanxing Chai‐Ho more than expected).

Fields of papers citing papers by Wanxing Chai‐Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanxing Chai‐Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanxing Chai‐Ho. The network helps show where Wanxing Chai‐Ho may publish in the future.

Co-authorship network of co-authors of Wanxing Chai‐Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Wanxing Chai‐Ho. A scholar is included among the top collaborators of Wanxing Chai‐Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanxing Chai‐Ho. Wanxing Chai‐Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignanciesbreakdown →
23
2 3
3 1
4 2
5 3
6 1
7 4
8 14
9 1
10 1
11 5
12 1
13 1
14 2
15
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trialbreakdown →
174
16 0
17 1
18 7
19 1
20 2

About Wanxing Chai‐Ho

Wanxing Chai‐Ho is a scholar working on Otorhinolaryngology, Oncology and Immunology, having authored 24 papers that have together received 298 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Virus-based gene therapy research (5 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Otorhinolaryngology (75 citations), Oncology (201 citations) and Immunology (85 citations). Wanxing Chai‐Ho has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Paul Swiecicki, Douglas R. Adkins, Gregory A. Daniels, Ezra E.W. Cohen, Emily Pittman, Kathryn A. Gold, Karen Messer, Scott M. Lippman, Julie Bykowski and Ruifeng Chen. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026